Sign in to view content

Safety and Efficacy of CRISPR-Based Genome Editing for Neovascular AMD

Glenn C. Yiu, MD, PhD

Video
Published 2023

Related

Suprachoroidal Delivery of RGX-314 for Neovascular AMD: Initial Results From the Phase II AAVIATE Study
Mark R. Barakat, MD
Updates from the Field
2021
Anti-VEGF treatment switch in DME and nAMD: a comparison of aflibercept versus ranibizumab after a single-dose switch
Estephania Feria, MD
On Demand Cases, Courses, and Papers
2019
OCT Angiography (OCTA) and Exudative Age-Related Macular Degeneration (ARMD)
Mark H. Nelson, MD, MBA
Updates from the Field
2017

Category: AMD-Neovascular

See more